Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment.
Journal Information
Full Title: Blood Adv
Abbreviation: Blood Adv
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict-of-interest disclosure: The authors declare no competing financial interests."
Funding Disclosure
Evidence found in paper:
"This study was supported by 10.13039/501100004826Beijing Natural Science Foundation (7212041), Clinical Research Incubation Project (Beijing Chao-Yang Hospital, Capital Medical University, CYFH202208), 10.13039/501100001809National Natural Science Foundation of China (81974011), and National High Level Hospital Clinical Research Funding (2022-PUMCH-B-048)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025